You are here

Article Text

Article menu
Download PDFPDF
Editorial
‘Brain fog’, MHT and dementia
  1. James A Cave
  1. The Downland Practice, Berkshire, UK
  1. Correspondence to Dr James A Cave, The Downland Practice, Berkshire, UK; jcave{at}bmj.com

https://doi.org/10.1136/dtb.2022.000064

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    It is estimated that 6 million women become menopausal each year worldwide.1 The impact that the changes associated with the menopause can have on women’s physical and mental health is receiving greater public attention through national and international campaigns.2 As a consequence of such campaigns (and despite well-reported shortages in availability for some products), prescriptions for menopause hormone therapy (MHT) in England continue to rise. Recent data show that the number of women prescribed MHT in 2021/2022 increased by half a million compared with the year before, bringing the total number to nearly 2 million.3 Increased interest in MHT has raised concerns over capacity in primary care to provide support for women seeking help for the menopause. In addition, evidence for the use of MHT is both complex and incomplete with significant gaps in some areas of research around the benefits and harms …

    View Full Text

    Footnotes

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; externally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.